Accuracy of high resolution (1.5 tesla) pelvic phased array magnetic resonance imaging (MRI) in staging prostate cancer in candidates for radical prostatectomy: Results from a prospective study

Urologic Oncology: Seminars and Original Investigations

Volumn 31, Issue 4, 2013, Pages 448-454

  Renard Penna, Raphaële ^a   Rouprêt, Morgan ^a   Comperat, Eva ^a   Ayed, Amine ^a   Coudert, Mathieu ^a   Mozer, Pierre ^a   Xylinas, Evanguelos ^a   Bitker, Marc Olivier ^a   Grenier, Philippe ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

MRI; Neoplasm staging; Prostate; Prostate specific antigen; Prostatic neoplasms

Indexed keywords

DOTAREM GUERBET; GADOTERATE MEGLUMINE; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER STAGING; DIAGNOSTIC ACCURACY; GLEASON SCORE; HUMAN; IMAGE ENHANCEMENT; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATECTOMY;

ADULT; AGED; DIGITAL RECTAL EXAMINATION; FOLLOW-UP STUDIES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; PELVIS; PROGNOSIS; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 84876699131     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2011.02.017     Document Type: Article

References (30)

1. Bill-Axelson A., Holmberg L., Ruutu M., et al. Radical prostatectomy vs. watchful waiting in early prostate cancer. N Engl J Med 2005, 352:1977-1984.
2. Jemal A., Bray F., Center M.M., et al. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
3. Ward J.F., Slezak J.M., Blute M.L., et al. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome. BJU Int 2005, 95:751-756.
4. Xylinas E., Drouin S.J., Comperat E., et al. Oncological control after radical prostatectomy in men with clinical T3 prostate cancer: A single-centre experience. BJU Int 2009, 103:1173-1178.
5. Bolla M., Collette L., Blank L., et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): A phase III randomized trial. Lancet 2002, 360:103-106.
6. Hsu C.Y., Joniau S., Oyen R., et al. Detection of clinical unilateral T3a prostate cancer-by digital rectal examination or transrectal ultrasonography?. BJU Int 2006, 98:982-985.
7. Lim C.H., Quinlan D.M. Are doctors examining prostates in university hospital?. Urology 2007, 70:843-845.
8. Philip J., Dutta Roy S., Ballal M., et al. Is a digital rectal examination necessary in the diagnosis and clinical staging of early prostate cancer?. BJU Int 2005, 95:969-971.
9. Cornud F., Flam T., Chauveinc L., et al. Extraprostatic spread of clinically localized prostate cancer: Factors predictive of pT3 tumor and of positive endorectal MR imaging examination results. Radiology 2002, 224:203-210.
10. Girouin N., Mege-Lechevallier F., Tonina Senes A., et al. Prostate dynamic contrast-enhanced MRI with simple visual diagnostic criteria: Is it reasonable?. Eur Radiol 2007, 17:1498-1509.
11. Villers A., Puech P., Mouton D., et al. Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: Correlation with radical prostatectomy findings. J Urol 2006, 176:2432-2437.
12. Jager G.J., Ruijter E.T., van de Kaa C.A., et al. Local staging of prostate cancer with endorectal MR imaging: Correlation with histopathology. AJR Am J Roentgenol 1996, 166:845-852.
13. Lemaitre L., Puech P., Poncelet E., et al. Dynamic contrast-enhanced MRI of anterior prostate cancer: Morphometric assessment and correlation with radical prostatectomy findings. Eur Radiol 2009, 19:470-480.
14. Futterer J.J., Engelbrecht M.R., Jager G.J., et al. Prostate cancer: Comparison of local staging accuracy of pelvic phased-array coil alone vs. integrated endorectal-pelvic phased-array coils. Local staging accuracy of prostate cancer using endorectal coil MR imaging. Eur Radiol 2007, 17:1055-1065.
15. Sobin L., Gospodarowicz M., Wittekind C. TNM Classification of Malignant Tumours. Urological Tumours 2009, 237-266. Wiley-Blackwell, Hoboken, NJ. 7th revised ed.
16. Pencina M.J., D'Agostino R.B. Overall C as a measure of discrimination in survival analysis: Model specific population value and confidence interval estimation. Stat Med 2004, 23:2109-2123.
17. Hsu C.Y., Joniau S., Oyen R., et al. Outcome of surgery for clinical unilateral T3a prostate cancer: A single-institution experience. Eur Urol 2007, 51:121-128. Discussion 128-9.
18. Hakenberg O.W., Frohner M., Wirth M.P. Treatment of locally advanced prostate cancer-the case for radical prostatectomy. Urol Int 2006, 77:193-199.
19. Carver B.S., Bianco F.J., Scardino P.T., et al. Long-term outcome following radical prostatectomy in men with clinical stage T3 prostate cancer. J Urol 2006, 176:564-568.
20. Van Poppel H., Goethuys H., Callewaert P., et al. Radical prostatectomy can provide a cure for well-selected clinical stage T3 prostate cancer. Eur Urol 2000, 38:372-379.
21. Aus G., Abbou C.C., Bolla M., et al. EAU guidelines on prostate cancer. Eur Urol 2005, 48:546-551.
22. Shikanov S.A., Zorn K.C., Zagaja G.P., et al. Trifecta outcomes after robotic-assisted laparoscopic prostatectomy. Urology 2009, 74:619-623.
23. Xylinas E., Ploussard G., Salomon L., et al. Intrafascial nerve-sparing radical prostatectomy with a laparoscopic robot-assisted extraperitoneal approach: Early oncological and functional results. J Endourol 2010, 24:577-582.
24. Futterer J.J. MR imaging in local staging of prostate cancer. Eur J Radiol 2007, 63:328-334.
25. Hricak H., White S., Vigneron D., et al. Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils vs. integrated endorectal-pelvic phased-array coils. Radiology 1994, 193:703-709.
26. Heijmink S.W., Futterer J.J., Hambrock T., et al. Prostate cancer: Body-array vs. endorectal coil MR imaging at 3 T-comparison of image quality, localization, and staging performance. Radiology 2007, 244:184-195.
27. Lee S.H., Park K.K., Choi K.H., et al. Is endorectal coil necessary for the staging of clinically localized prostate cancer? Comparison of non-endorectal vs. endorectal MR imaging. World J Urol 2010, 28:667-672.
28. Katahira K., Takahara T., Kwee T.C., et al. Ultra-high b-value diffusion-weighted MR imaging for the detection of prostate cancer: Evaluation in 201 cases with histopathologic correlation. Eur Radiol 2011, 21:188-196.
29. Latchamsetty K.C., Borden L.S., Porter C.R., et al. Experience improves staging accuracy of endorectal magnetic resonance imaging in prostate cancer: What is the learning curve?. Can J Urol 2007, 14:3429-3434.
30. Futterer J.J., Engelbrecht M.R., Huisman H.J., et al. Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: Experienced vs. less experienced readers. Radiology 2005, 237:541-549.